{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:18:47Z","timestamp":1753888727268,"version":"3.41.2"},"reference-count":32,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202466027","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:32:32Z","timestamp":1715596352000},"source":"Crossref","is-referenced-by-count":0,"title":["Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment"],"prefix":"10.1590","volume":"66","author":[{"given":"Jia","family":"Luo","sequence":"first","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yuan","sequence":"additional","affiliation":[{"name":"Chongqing Medical and Pharmaceutical College,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingsha","family":"Zhou","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailan","family":"Li","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyuan","family":"Bai","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Zeng","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyi","family":"Sun","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongfang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6523-9747","authenticated-orcid":false,"given":"Li","family":"Zhou","sequence":"additional","affiliation":[{"name":"Chongqing Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po C","year":"2014","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer A","year":"2015","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000333258","article-title":"Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection","volume":"81","author":"Kim BK","year":"2011","journal-title":"Oncology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jmv.25692","article-title":"Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B","volume":"92","author":"Tamaki N","year":"2020","journal-title":"J Med Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jgh3.12273","article-title":"Hepatitis B surface antigen reduction as a result of switching from long-term entecavir administration to tenofovir","volume":"4","author":"Tamaki N","year":"2020","journal-title":"JGH Open"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/hepr.13227","article-title":"Suppression of hepatitis B surface antigen production by combination therapy with nucleotide analogues and interferon in children with genotype C hepatitis B virus infection","volume":"48","author":"Tajiri H","year":"2018","journal-title":"Hepatol Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jmv.25515","article-title":"Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B","volume":"91","author":"Hagiwara S","year":"2019","journal-title":"J Med Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1111\/jgh.14686","article-title":"Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate","volume":"34","author":"Kaneko S","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/hepr.13497","article-title":"Artificial liver treatment improves survival in patients with hepatitis B virus-related acute-on-chronic liver failure: a case-control matched analysis","volume":"50","author":"Yang L","year":"2020","journal-title":"Hepatol Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jhep.2012.10.025","article-title":"Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis","volume":"58","author":"Kumada T","year":"2013","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/hepr.13399","article-title":"Entecavir treatment of hepatitis B virus-infected patients with severe renal impairment and those on hemodialysis","volume":"49","author":"Suzuki K","year":"2019","journal-title":"Hepatol Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang HI","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jhep.2020.01.007","article-title":"Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B","volume":"72","author":"Papatheodoridis GV","year":"2020","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.cgh.2016.05.039","article-title":"Association between level of fibrosis, rather than antiviral regimen, and outcomes of patients with chronic hepatitis B","volume":"14","author":"Kim HS","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cld.2016.06.003","article-title":"Liver fibrosis reversion after suppression of hepatitis B virus","volume":"20","author":"Rockey DC","year":"2016","journal-title":"Clin Liver Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cgh.2010.11.040","article-title":"Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B","volume":"9","author":"Schiff ER","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin P","year":"2013","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhep.2008.10.014","article-title":"Liver biopsy: the best, not the gold standard","volume":"50","author":"Bedossa P","year":"2009","journal-title":"J Hepatol"},{"year":"2015","series-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","key":"ref20"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/jgh.13473","article-title":"Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: an analysis using time-dependent receiver operating characteristic","volume":"32","author":"Tada T","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach JK","year":"2018","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling RK","year":"2006","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.2008.03895.x","article-title":"The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B","volume":"29","author":"Mallet V","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/apt.13191","article-title":"Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study","volume":"41","author":"Fu SC","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ajg.2014.157","article-title":"Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy","volume":"109","author":"Lee HW","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MEG.0000000000001592","article-title":"Dynamic prediction of liver cirrhosis risk in chronic hepatitis B patients using longitudinal clinical data","volume":"32","author":"Wang Y","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag JL","year":"2003","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang TT","year":"2010","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jvh.13457","article-title":"Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis","volume":"28","author":"Kumada T","year":"2021","journal-title":"J Viral Hepat"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.dld.2014.01.003","article-title":"Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy","volume":"46","author":"Ieluzzi D","year":"2014","journal-title":"Dig Liver Dis"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652024000100214&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:32:44Z","timestamp":1715596364000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652024000100214&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":32,"alternative-id":["S0036-46652024000100214"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202466027","relation":{},"ISSN":["1678-9946"],"issn-type":[{"type":"electronic","value":"1678-9946"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e27"}}